282 filings
8-K
RSPI
RespireRx Pharmaceuticals Inc.
29 May 24
Regulation FD Disclosure
9:03am
8-K
RSPI
RespireRx Pharmaceuticals Inc.
16 Apr 24
Entry into a Material Definitive Agreement
4:05pm
8-K
RSPI
RespireRx Pharmaceuticals Inc.
2 Feb 24
Entry into a Material Definitive Agreement
8:30am
8-K
RSPI
RespireRx Pharmaceuticals Inc.
22 Jan 24
RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
8:45am
8-K
RSPI
RespireRx Pharmaceuticals Inc.
11 Dec 23
Entry into a Material Definitive Agreement
8:45am
8-K
c6m0fqdd
12 Oct 23
RespireRx Pharmaceuticals Inc.’s Subsidiary ResolutionRx Ltd Enters into Master Services Agreement for Dronabinol Manufacturing and Related Services
9:00am
8-K
gu85 8frqd
2 Oct 23
Settlement and Exchange Agreement
8:45am
8-K
kl4iyj
9 Aug 23
RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
8:52am
8-K
heil5
13 Jun 23
Template of Form of Phantom Stock Award Agreement
4:10pm
8-K
1amiz qmr7vj
24 May 23
Entry into a Material Definitive Agreement
8:45am
8-K
w4honv
5 May 23
Regulation FD Disclosure
4:05pm
8-K
76gmv8x73 xmf0gmd
13 Apr 23
Entry into a Material Definitive Agreement
8:30am
8-K
e09k7tsed74mc
6 Apr 23
Form of Securities Purchase Agreement
8:30am
8-K
tp1ojloini1ppes
28 Mar 23
RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
8:55am
8-K
0wx32jirh8pq4mict
1 Mar 23
ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx’s Entry into a Services Agreement with iNGENu CRO Pty Ltd
8:50am
8-K
bpge1dg9
1 Feb 23
Regulation FD Disclosure
8:45am
8-K
oa0nu4a yoj
23 Jan 23
RespireRx Pharmaceuticals Inc. Announces the 2nd Amendment to its License Agreement with the University of Illinois
8:45am
8-K
likd 7juz1k9m2tn
12 Jan 23
RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
9:00am
8-K
nby7upmco7gu3zhx7
17 Nov 22
Regulation FD Disclosure
9:00am
8-K
1qx3nu 04y5
10 Nov 22
RespireRx Pharmaceuticals Inc. Announces that Jeff Margolis, the Company’s CFO is presenting at the Investor Summit Q4
9:00am